Merck & Co., Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 14.7B 13.5B 13.2B 13.3B
Cost of revenue 3.3B 3.0B 2.9B 3.3B
Gross profit 11.4B 10.4B 10.3B 10.1B
Operating expense
Research & development 3.6B 3.4B 3.1B 3.9B
Selling general and admin 2.2B 2.3B 2.2B 2.4B
Other operating expenses
Operating income 5.6B 4.7B 5.1B 3.7B
Non operating interest income
Income 81.8M 58.8M 92.9M 124.4M
Expense 278.7M 259.9M 266.8M 279.5M
Other income expense 359.6M -270.2M 144.9M 3.4M
Pretax income 5.7B 4.3B 5.0B 3.6B
Tax provision 816.5M 486.6M 697.1M 363.1M
Net income 4.9B 3.8B 4.3B 3.2B
Basic EPS 2.3 1.8 2.0 1.5
Diluted EPS 1.8 2.0 1.5
Basic average shares 2.1B 2.1B 2.1B 2.2B
Diluted average shares 2.1B 2.2B 2.2B
EBITDA 6.8B 5.9B 6.3B 5.1B
Net income from continuing op. 4.9B 3.8B 4.3B 3.2B
Minority interests -1.7M -852.3K -5.1M -852.3K
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 48 minutes

08:06
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).